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Integrating GWAS and Expression Data for Functional
Characterization of Disease-Associated SNPs:
An Application to Follicular Lymphoma
Lucia Conde,1,4 Paige M. Bracci,2 Rhea Richardson,3 Stephen B. Montgomery,3,*
and Christine F. Skibola1,4,*
Development of post-GWAS (genome-wide association study) methods are greatly needed for characterizing the function of trait-
associated SNPs. Strategies integrating various biological data sets with GWAS results will provide insights into the mechanistic role
of associated SNPs. Here, we present a method that integrates RNA sequencing (RNA-seq) and allele-specific expression data with
GWAS data to further characterize SNPs associated with follicular lymphoma (FL). We investigated the influence on gene expression
of three established FL-associated loci—rs10484561, rs2647012, and rs6457327—bymeasuring their correlation with human-leukocyte-
antigen (HLA) expression levels obtained from publicly available RNA-seq expression data sets from lymphoblastoid cell lines. Our
results suggest that SNPs linked to the protective variant rs2647012 exert their effect by a cis-regulatory mechanism involving modula-
tion of HLA-DQB1 expression. In contrast, no effect on HLA expression was observed for the colocalized risk variant rs10484561. The
application of integrative methods, such as those presented here, to other post-GWAS investigations will help identify causal disease
variants and enhance our understanding of biological disease mechanisms.Follicular lymphoma (FL [MIM 613024]), a common
subtype of non-Hodgkin lymphoma (NHL [MIM
605027]), is a heterogeneous malignancy of the lymphoid
system. Genome-wide association studies (GWASs) have
identified several major susceptibility loci for FL in the
human-leukocyte-antigen (HLA) region; these loci include
SNPs in HLA class II (rs10484561 [p ¼ 1.12 3 1029]1 and
rs2647012 [p ¼ 2 3 1021]2) and class I (rs6457327 [p ¼
4.7 3 1011]3) regions. However, despite additional work
that uncovered possible biological relevance of these asso-
ciated variants,4 their function remains to be established.
Recent advances in genetic studies on gene expression
provide new opportunities for connecting trait-predispos-
ing variants to cellular mechanisms.5,6 Such studies have
already refined candidate-gene selection in numerous
GWASs by identifying expression quantitative trait loci
(eQTLs) that coordinately influence study traits and gene
expression.7–9 In this study, we used existing GWAS data
to investigate the influence on gene expression of
rs2647012, rs6457327, and rs10484561 bymeasuring their
correlation with RNA-sequencing (RNA-seq) data, and we
made use of allele-specific-expression (ASE) data to assesses
the enrichment of both rare and common causal effects for
individuals harboring both protective and risk haplotypes
(Figure 1).
As a result of the high linkage disequilibrium (LD) in the
region and the possibility that the three FL-associated
variants (rs10484561, rs2647012, and rs6457327) could
be linked to potential eQTLs, we expanded the eQTL
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Europe from the CEPH collection) genotype data (release
28), we identified 290 SNPs in LD (r2 > 0.5) with the three
FL-associated variants. To confirm the role of these linked
variants in FL risk, we tested them for association by using
genotype data from a previous GWAS of FL.1 SNPs not
genotyped or not passing quality-control criteria in the
FL GWAS were imputed with BEAGLE 3.310 with the use
of phased genotype data for 85 CEU samples from phase
I of the 1000 Genomes Project. Those variants that did
not show statistical evidence of association with FL (trend
p value < 1.673 102 based on a Bonferroni correction for
the three loci tested with a ¼ 0.05) or for which no associ-
ation data were available were further discarded, leading to
the inclusion of an additional 158 variants in LD (55, 45,
and 61 variants linked to rs10484561, rs2647012, and
rs6457327, respectively) in the eQTL analysis.
To test the correlation between genetic variation and
expression levels in the FL-associated loci, we used publicly
available gene-expression and genotype data from
HapMap CEU individuals. Whole-genome expression
data in transformed lymphoblastoid cell lines (LCLs) ob-
tained by RNA sequencing (RNA-seq) were downloaded
from two data sets. The first data set (GSE16921)11 con-
tained processed gene-expression RPKM (reads per kilobase
per million mapped reads) values from 41 CEU samples
and was downloaded from the Gene Expression Omnibus.
eQTL transcript association data from 60 CEU samples,
29 of which were shared with GSE16921, were obtained
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Figure 1. ASE Test for Disease-Associated Variants
ASE that is shared among multiple individuals can indicate the
presence of an eQTL (i.e., individuals with ASE are heterozygous
for the common causal regulatory variant), multiple rare regula-
tory variants (i.e., each individual has a private variant impacting
expression), or epigenetic effects where one haplotype is silenced
relative to the other. We have developed a method that assesses
enrichment of ASE effects for individuals harboring both the risk
and the protective alleles (i.e., individuals who are heterozygous
for the GWAS variant) as compared to homozygous individuals.
Here, the expectation is that functional differences will be more
manifest for individuals who possess both the risk and protective
alleles for genes involved in the etiology of the trait. This enrich-
ment is represented in the figure in that more ASE events are
present in individuals heterozygous for the GWAS variant; green
ratios describe the relative transcript abundance. This test comple-
ments eQTL approaches in that it can add support to the presence
of an eQTL, as well as indicate an enrichment of other potential
causal effects (independent of frequency) (i.e., rare or private vari-
ants) underlying the difference in risk and protective haplotypes.generated by Montgomery et al.12 and downloaded from
their website. Whole-genome genotyping data for the
same HapMap CEU individuals were directly downloaded
from HapMap. Although eQTLs can have a distant (trans)
effect, we focused here on proximal (cis) eQTLs, and we
therefore tested each of the 161 investigated SNPs as an
eQTL, and all expression probes were located within 1
Mb of the SNP. For the E-MTAB-197 data set, eQTL associ-
ation data, measured by Spearman’s rank correlation, were
directly obtained from the website of Montgomery et al.
For GSE16921, the correlation between expression and
genotype for each SNP-probe pair was tested with the
Spearman’s rank correlation test with t-distribution
approximation. All the correlations between genotype
and expression were estimated with respect to the minor
allele. p values were adjusted for multiple comparisons
with the Benjamini-Hochberg false-discovery-rate (FDR)
correction (p values and thresholds adjusted with this
correction are henceforth referred to as BH p values and
thresholds, respectively). eQTLs were considered signifi-
cant at a BH p value threshold ¼ 0.01.
Using the GSE16921 RNA-seq expression data set, we
found a total of 192 SNP-probe pairs, corresponding to
66 individual SNPs, that reached statistical significance inThe Americthe eQTL analysis (Table S1, available online). Interest-
ingly, all 45 SNPs linked to rs2647012 showed significant
expression changes in nearby genes. In particular, these
FL protective variants were consistently associated with
higher expression levels of HLA-DQA1 (MIM 146880),
HLA-DQB1 (MIM 604305), HLA-DRB1 (MIM 142857),
and HLA-DRB5 (MIM 604776) and lower expression levels
of HLA-DQA2 (MIM 613503), HLA-DQB2, and HLA-DRB6
(Table S1). Variants linked to the FL-protective SNP
rs6457327 significantly correlated with higher HCG22
(MIM 613918) expression (Table S1). However, none of
the rs10484561-linked SNPs exhibited significant associa-
tion with expression changes in any surrounding genes
in this RNA-seq data set. To corroborate these findings,
we used eQTL data obtained from the E-MTAB-197 data
set. In this independent RNA-seq data set, 50 eQTLs
reached statistical significance at the BH threshold of p <
0.01 (Table S1). Considerable reproducibility was found
between both RNA-seq data sets for the shared SNP-gene
combinations at rs2647012-linked SNPs. Thus, we again
observed higher HLA-DQA1, HLA-DQB1, HLA-DRB1, and
HLA-DRB5 expression levels and lower HLA-DQA2 expres-
sion levels for rs2647012-linked variants (Table S1). Associ-
ations between rs2647012 SNPs and HLA-DQB2 and
HLA-DRB6, as well as associations between rs6457327 vari-
ants and HCG22, could not be confirmed because no infor-
mation for these genes was included in E-MTAB-197.
However, additional correlations were observed between
rs2647012 SNPs and HLA-DRA (MIM 142860) expression
and between rs6457327 SNPs and C6orf26 and HLA-B
(MIM 142830) expression in E-MTAB-197 (Table S1). As
with the previous data set, no eQTLs were found for the
rs10484561-linked SNPs at a BH threshold of p % 0.01.
Overall, the most significant eQTL associations in both
RNA-seq data sets were seen for rs2647012-linked variants
and HLA-DQB1 (Table S2 and Figure S1). Of the 45 SNPs
investigated in this locus, 32 were associated with differen-
tial HLA-DQB1 levels and 30 consistently correlated with
increased HLA-DQB1 expression. Of theHLA-DQB1 eQTLs,
the strongest FL-associated SNP was rs4947344, which
showed differential expression for multiple HLA genes
(Table S2 and Figure S2). To explore the potential trans-
effect of these eQTLs, we also investigated the correlation
between rs2647012-linked SNPs and genome-wide expres-
sion levels in the GSE16921 data set. We observed that
the strongest correlations were found with genes nearby
(Figure 2 and Figure S3), further suggesting that
rs2647012 variants are cis-regulatory. To further corrobo-
rate the potential regulatory effect of FL-associated SNPs
on HLA-DQB1, we developed a complementary ASE-based
approach (Figure 1). Using this strategy, we first assessed
ASE in HapMap CEU individuals heterozygous at HLA-
DQB1 exonic SNPs. ASE, calculated as previously re-
ported,13 was assessed exclusively for sites identified as
heterozygous in matching individuals sequenced as part
of the 1000 Genomes Project Low-Coverage Pilot data
set. Only heterozygous variants with a read depth R 8an Journal of Human Genetics 92, 126–130, January 10, 2013 127
Figure 2. Genome-wide SNP-Probe Associations for rs4947344
in the GSE16921 Data Set
SNP-probe association plot for rs4947344 and probes located
across the genome. The strongest associations, represented
as log10 of the Spearman’s observed p value, were observed for
HLA class II genes located in cis with respect to rs4947344. A
genome-wide association plot for all the rs2647012-linked vari-
ants is shown in Figure S3.and observed imbalance level from 15% to 85% were
included in the analysis. In total, 162,114 pairs of hetero-
zygous SNP-sample pairs were tested for allelic imbalance,
and 3,441 (2.1%) pairs showed evidence of allelic imbal-
ance at a p value level < 2.12 3 104, corresponding to
a FDR of 1%. Among the 317 HLA-DQB1 SNP-sample pairs
for which ASE data were available, 132 (41.6%) were imbal-
anced at p < 2.12 3 104 (FDR ¼ 1%). The presence of ASE
can reflect the presence of nearby cis-regulatory polymor-
phisms.13 If ASE is marking a cis-eQTL, individuals with
ASE should also be heterozygous for that eQTL. However,
the enrichment of allelic effects does not explicitly require
the presence of a common eQTL and could be tagging
multiple rare effects (Figure 1). Therefore, we tested
whether the ASE-significant signals for linked alleles in
HLA-DQB1 were more enriched in samples heterozygous
for the FL-associated variants than in homozygous
samples. We found convincing evidence of enrichment
of allelic imbalance for samples heterozygous for the FL-
associated variants linked to rs2647012 (Table S3 and
Figure S4), and rs4947344 was the FL-associated variant
most significantly enriched with ASE-significant signals
(p value ¼ 1.28 3 104, Table S3). A second rs2647012-
linked SNP, rs9275292, which approached statistical signif-
icance in the previous eQTL analysis (BH p value ¼ 1.08 3
102), also showed significant enrichment of allelic imbal-
ance (p value ¼ 9.58 3 105, Table S3). No ASE data were
available for HLA-DRB1, HLA-DRB6, or HLA-DQA2, yet
we found 312 pairs of heterozygous HLA-DQA1 SNP-
sample pairs, 33 (10.6%) of which had significant ASE.
However, there was no enrichment of allelic effect
on HLA-DQA1 for samples heterozygous for rs2647012-
linked SNPs.
rs10484561 and rs2467012 lie in close proximity within
an intergenic region and are 29 and 28 kb, respectively,128 The American Journal of Human Genetics 92, 126–130, January 1upstream of HLA-DQB1 (Figure S5). Although located in
the same region as rs2647012, none of the SNPs linked
to rs10484561 showed eQTLs for HLA-DQB1 (Table S4),
suggesting that different mechanisms are most likely
involved for these two FL-associated loci. However,
rs10484561 did show moderate enrichment of ASE effects
(Figure S6). To elucidate the potential mechanisms on
expression regulation underlying the HLA-DQB1 eQTLs
linked to rs2647012, we compared the regulatory context
of the rs2647012 and rs10484561 regions by using
ENCODE (Encyclopedia of DNA Elements) experimental
data. LCL analyses using chromatin immunoprecipitation
followed by high-throughput sequencing (ChIP-seq) re-
vealed several histone marks and transcription-factor
binding sites associated with enhancer and silencer activi-
ties in the region, overlapped by both rs2647012- and
rs10484561-linked variants (Tables S3 and S4). However,
there was no significant enrichment of specific transcrip-
tion factors or epigenetic marks to explain the eQTL- and
ASE-effect differences observed between rs2647012- and
rs10484561-linked SNPs. A search using the HaploReg
resource14 provided similar results without pinpointing
particular regulatory motifs that could account for the
differences observed between both loci.
However, because the FL-protective rs2647012-linked
variants are correlated with increased HLA-DQB1 ex-
pression, our results suggest that reduced HLA-DQB1
expression might play a key role in the pathogenesis
of lymphoma. In contrast, the colocalizing variant
rs10484561 does not seem to modulate HLA-DQB1
through a common eQTL effect or through expression of
other HLA class II genes. The functional relevance of this
variant might relate to its high LD (D0 > 0.9) with the
HLA-DQB1*0501 and HLA-DRB1*0101 coding alleles.4
The structural changes of these HLA alleles at the amino
acid level might affect antigen binding and overall
immune response, providing a feasible mechanism by
which rs10484561-linked variants might act. Furthermore,
the moderate enrichment of ASE effects indicates the
potential for rare regulatory variants interacting with
protein-coding variants that contribute to this effect. In
the HLA class I region, association between the FL-protec-
tive rs6457327 SNPs and HLA-expression changes were
more inconsistent. The E-MTAB-197 data set indicated
a correlation between the SNPs and C6orf26 and HLA-B;
however, these associations were not observed in the
GSE16921 data set, which instead showed association
with HCG22. SNP rs6457327 has been associated with
the transformation of FL to diffuse large-B cell lym-
phoma,15,16 a more aggressive form of NHL, as well as
with survival.16 However, the strength of the disease-risk
association between rs6457327 and FL has been less robust
than that between HLA class II variants and FL.1 It is
possible that variants in this region exert more subtle
effects, and therefore, larger data sets are needed for
unequivocally determining the potential effect of those
variants on the expression of nearby genes. Additionally,0, 2013
there is increasing evidence that the effect of eQTLs differs
by cell type. Therefore, it is possible that the lack of eQTL
evidence for rs10484561 and rs6457327 might be due to
different mechanisms involving transcription factors not
expressed in LCLs. Although it has been observed that
LCLs are good surrogates for primary tissue and that
genetic variation in LCLs might be generalized to primary
B cells,17 Epstein-Barr-virus transformation might have an
impact on gene regulation in B lymphocytes. Therefore,
further analysis of primary B cells and other antigen-pre-
senting cells will provide a further understanding of the
potential regulatory effects of these FL-associated variants
in primary cell types. Finally, it is likely that other factors
not examined in this study exert additional functional
effects. In particular, gene-gene and gene-environment
interactions probably play a role in FL pathogenesis, and
follow-up studies that take into account these additional
factors are likely to provide further insight.
GWASs have proven very successful for the discovery of
SNPs associated with complex diseases, and now there is
an increasing need to explore their potential functional
relevance. In this study, we focused on three FL suscepti-
bility loci to determine whether expression changes can
be linked to FL pathogenesis. We used an ASE-based
approach designed to capture enrichment of common
and rare regulatory variants and epigenetic effects for
individuals carrying both protective and risk alleles. Ulti-
mately, methods that incorporate diverse genomic data
will enhance our understanding of mechanisms involved
in the etiology of complex diseases.Supplemental Data
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